Endry Septiadi
Department of Nutrition, Faculty of Medicine, Universitas Jenderal Achmad Yani, Cimahi, Indonesia.

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

The duration of Mediterranean diet affects the levels of the lipid profile in dyslipidemia patients Dewi R Handayani; Endry Septiadi; Iis Inayati; Siska T Pratiwi; Rifal A Anugrah; Nur M Rohman; Achmad H Prawira; Muhammad A Rais
ACTA Medical Health Sciences Vol. 1 No. 2 (2022): ACTA Medical Health Sciences
Publisher : ACTA Medical Health Sciences

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (290.488 KB)

Abstract

Dyslipidemia is a lipid metabolism disorder that indicates abnormal levels of lipid profile inplasma. The most notable lipid profile abnormalities include increased levels of total cholesterol, low-density lipoprotein cholesterol (LDL), triglycerides, and a decrease in high-density lipoprotein cholesterol (HDL). One of the non-pharmacological management for dyslipidemia is diet modification with the Mediterranean diet. This study aims to determine therelationship between the duration of the Mediterranean diet and lipid profile levels in Prolanispatients who experience dyslipidemia in a clinic in Bandung. The research method wasanalytical with cohort observations. Sampling was done by consecutive sampling. Subjects inthis study were 30 dyslipidemic patients who followed a Mediterranean diet and were examinedfor lipid profile levels in the first and third months. Data on total cholesterol, LDL, HDL, andtriglycerides were analyzed using the T-dependent test. Total cholesterol and Triglyceridesdecreased significantly, and HDL increased significantly in the first and third month. Theduration of the Mediterranean diet shows a reduction effect of total cholesterol, LDL,triglycerides and significantly increase HDL in patients with dyslipidemia because therecommended foods are high in monounsaturated fatty acids (MUFA) and polyunsaturated fattyacids (PUFA), which can correct abnormalities in lipid profile levels.   DOI : 10.35990/amhs.v1n2.p64-70